Quick Answer
Neurogene Inc. reported Net Income of -$90.35 million for fiscal year 2025.
Neurogene Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$90.35M | -20.2% |
| 2024 | -$75.14M | -106.9% |
| 2023 | -$36.32M | +34.2% |
| 2022 | -$55.19M | +9.1% |
| 2021 | -$60.69M | -82.4% |
| 2020 | -$33.28M | +52.1% |
| 2019 | -$69.44M | -119.9% |
| 2018 | -$31.59M | +37.1% |
| 2017 | -$50.18M | -35.6% |
| 2016 | -$37.00M | -69.3% |
| 2015 | -$21.86M | +9.0% |
| 2014 | -$24.03M | -175.3% |
| 2013 | -$8.73M | -13.2% |
| 2012 | -$7.71M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$20.95M | -3.6% | +4.8% |
| June 30, 2025 | -$22.02M | -19.1% | +2.8% |
| March 31, 2025 | -$22.65M | -33.8% | -12.0% |
| September 30, 2024 | -$20.22M | -38.7% | -9.3% |
| June 30, 2024 | -$18.49M | -55.9% | -9.3% |
| March 31, 2024 | -$16.92M | -38.0% | -16.1% |
| September 30, 2023 | -$14.58M | -11.5% | -22.9% |
| June 30, 2023 | -$11.86M | +24.4% | +3.3% |
- Neurogene Inc. showed a decrease of -20.2% in Net Income compared to the prior fiscal year.
- Over the 2012–2025 period, Neurogene Inc.’s net income has declined by 1071.2% (from -$7.71 million to -$90.35 million).
- The most recent figure is from Neurogene Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: